🔎 Trials Near Me

Hjem › Lymfom › Illinois › Chicago

Kliniske studier for Lymfom i Chicago, IL

20 studier for Lymfom søker deltakere på steder i og rundt Chicago (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.

Offisiell studietekst (engelsk)

Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →

A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma

RekruttererFase 2
  • Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT07015242

CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

RekruttererFase 1/2
  • Lurie Children's Hospital-Chicago, Chicago
  • University of Chicago Comprehensive Cancer Center, Chicago
12 Months – 21 Years · Alle kjønn · Oppdatert 11. sep. 2026 · NCT04870944

A Study Evaluating the Safety and Efficacy of Glofitamab + Gemcitabine + Oxaliplatin in U.S. Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

RekruttererFase 1
  • University of Illinois Cancer Center, Chicago
Alder 18 og eldre · Alle kjønn · Oppdatert 8. sep. 2026 · NCT06624085

Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell Malignancies

RekruttererFase 1/2
  • University of Chicago, Chicago
Alder 18 og eldre · Alle kjønn · Oppdatert 28. aug. 2026 · NCT07284433

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

RekruttererFase 1/2
  • University of Chicago Medical Center, Chicago
Alder 18 og eldre · Alle kjønn · Oppdatert 19. aug. 2026 · NCT04104776

A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies

RekruttererFase 1
  • The David and Etta Jonas Center for Cellular Therapy, Chicago
Alder 18 og eldre · Alle kjønn · Oppdatert 17. aug. 2026 · NCT06528301

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

RekruttererFase 3
  • Northwestern, Chicago
  • University of Chicago, Chicago
Alder 18 og eldre · Alle kjønn · Oppdatert 4. aug. 2026 · NCT07188558

Mosaic Trial for Stem Cell Transplant Recipients

Rekrutterer
  • Northwestern University Feinberg School of Medicine, Chicago
Alder 18 og eldre · Alle kjønn · Oppdatert 3. aug. 2026 · NCT06960993

DALY II USA/ MB-CART2019.1 for DLBCL

RekruttererFase 2
  • Robert H Lurie Cancer Center, Chicago
Alder 18 og eldre · Alle kjønn · Oppdatert 13. jul. 2026 · NCT04792489

A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)

RekruttererFase 1/2
  • Call for Information (Investigational Site 0024), Chicago
6 Months – 17 Years · Alle kjønn · Oppdatert 6. jul. 2026 · NCT02332668

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

RekruttererFase 1
  • Northwestern University, Chicago
Alder 18 og eldre · Alle kjønn · Oppdatert 2. jul. 2026 · NCT05131022

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

RekruttererObservasjonsstudie
  • Lurie Children's Hospital-Chicago, Chicago
Alle aldre · Alle kjønn · Oppdatert 18. mai 2026 · NCT01790152

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

RekruttererFase 1/2
  • Northwestern Memorial Hospital, Chicago
Alder 18 og eldre · Alle kjønn · Oppdatert 16. apr. 2026 · NCT03328078

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

RekruttererFase 1/2
  • University of Illinois at Chicago Cancer Center, Chicago
Alder 12 til 95 · Alle kjønn · Oppdatert 15. apr. 2026 · NCT04329728

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

RekruttererFase 1
  • The University of Chicago Medical Center, Chicago
Alder 18 og eldre · Alle kjønn · Oppdatert 20. mar. 2026 · NCT04830137

CApivasertib, Venetoclax And Low-intensity chemotheRapY for Adults With ALL/LBL

RekruttererFase 1/2
  • University of Chicago Medicine Comprehensive Cancer Center, Chicago
Alder 18 og eldre · Alle kjønn · Oppdatert 4. mar. 2026 · NCT07294677

Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care

Rekrutterer
  • University of Chicago Comprehensive Cancer Center, Chicago
Alder 18 og eldre · Alle kjønn · Oppdatert 20. feb. 2026 · NCT05745285

Avo In R/R And Previously Untreated MCL

RekruttererFase 1/2
  • University of Chicago Medical Center, Chicago
Alder 18 og eldre · Alle kjønn · Oppdatert 21. jan. 2026 · NCT04855695

Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma

RekruttererFase 1
  • Northwestern University, Robert H. Lurie Comprehensive Cancer Center, Chicago
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2025 · NCT04234048

Lymfom-studier i andre byer

Andre studier i Chicago

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.